Previous in vivo studies that implicated TLR4 in S100A8 and S100A8/A9 mediated inflammation have done so largely in the context of endotoxemia, where TLR4 would be readily activated [22,46]. Here, S100A8 is linked to serum lipopolysaccharide activity.